ABOUT US

Novilytic is a biochemistry analytics company that protects and secures lifesaving drugs and medical devices.   

 

The company is backed by: 

  • >25 patents 

  • $2B Analytical Instrument Co. 

  • 2 Pharmaceutical Consortiums 

  • 2 Med & Analytical Universities 

 

Our potency is extended by our people which includes 5 Ph.D. chemists and engineers who have helped us secure significant patents and other IP.  Our business plan will increase those forces to ensure we meet customer, market, and regulatory demands. ​

1/4

The Novilytic Product Lines complete the balance of Novilytic’s strength. They include: 

 

  • The Proteometer™ - Disruptive Instrument for pharmaceutical processing 

  • NoviChrom™ Analytical Columns 

  • Consumables for the Proteometer 

  • NoviQuest™ & NoviMASC Reagents 

  • Consumables for the Proteometer 

  • NoviPlex™ Blood Collection Devices - Most advanced global collection device 

Novilytic is pursuing seed funding to bring the Proteometer to market. With significant strategic advantages, patents, and other IP, Novilytic is expected to experience significant growth over the next 3-4 years. 

Partners

Paul 1.jpg
Paul C. Dreier,
BSc., MBA

Chief Executive Officer

Fred (Ryan's Choice).jpg
Fred E. Regnier,
Ph.D.

Chief Technology Officer

Jiri 3.jpg
Jiri Adamec,
Ph.D.

Co-Founder & Technical Counsel

Tim 1.jpg
Timothy E. Woenker, BSc.

Chief Operating Officer

Team

AWP-21.jpg
Jinhee Kim,
Ph.D.

Director of Analytics

Meena 2.jpg
Meena L. Narsimhan, Ph.D.

Director of Process Technology

Eric Headshot .JPG
Eric Bowen,
BSc., MBA

Staff Analytical Scientist

Nadine 1.jpg
Nadine Njoya-Honn, Ph.D.

Director of Novichrom Chemistries

 
Mary (Ryan's Choice).jpg
Mary Bower

Staff Analytical Scientist

Nathan 1.jpg
Nathan Morris

Staff Analytical Scientist

Ryan 1.jpg
Ryan Simpson

Marketing Manager

Joye Updated Choice.jpg
Joye Fisher

Office Manager